CABANA trial: “beauty is in the eye of the beholder”

David Briceno, Prasant Mohanty, Luigi Di Biase, Jorge Romero, Domenico Giovanni Della Rocca, Chintan Trivedi, Sanghamitra Mohanty, Andrea Natale

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations


The CABANA trial reported that catheter ablation, when compared with drug therapy, did not significantly reduce the primary composite end point of death, disabling stroke, serious bleeding, or cardiac arrest in patients with atrial fibrillation. Despite multiple limitations in study design, the CABANA trial still confirmed that catheter ablation of atrial fibrillation led to clinically important and significant improvements in quality of life at 12 months without increasing the risk of complications.

Original languageEnglish (US)
JournalJournal of Interventional Cardiac Electrophysiology
Issue number1
StatePublished - Jan 1 2020


  • Ablation
  • Atrila fibrillation
  • Mortality
  • Outcomes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)


Dive into the research topics of 'CABANA trial: “beauty is in the eye of the beholder”'. Together they form a unique fingerprint.

Cite this